Abstract:In a subset of patients, chronic exposure to stress is an etiological risk factor for neuroinflammation and depression. Neuroinflammation affects up to 27% of patients with MDD and is associated with a more severe, chronic, and treatment-resistant trajectory. Inflammation is not unique to depression and has transdiagnostic effects suggesting a shared etiological risk factor underlying psychopathologies and metabolic disorders. Research supports an association but not necessarily a causation with depression. Putative mechanisms link chronic stress to dysregulation of the HPA axis and immune cell glucocorticoid resistance resulting in hyperactivation of the peripheral immune system. The chronic extracellular release of DAMPs and immune cell DAMP-PRR signaling creates a feed forward loop that accelerates peripheral and central inflammation. Higher plasma levels of inflammatory cytokines, most consistently interleukin IL-1β, IL-6, and TNF-α, are correlated with greater depressive symptomatology. Cytokines sensitize the HPA axis, disrupt the negative feedback loop, and further propagate inflammatory reactions. Peripheral inflammation exacerbates central inflammation (neuroinflammation) through several mechanisms including disruption of the blood-brain barrier, immune cellular trafficking, and activation of glial cells. Activated glial cells release cytokines, chemokines, and reactive oxygen and nitrogen species into the extra-synaptic space dysregulating neurotransmitter systems, imbalancing the excitatory to inhibitory ratio, and disrupting neural circuitry plasticity and adaptation. In particular, microglial activation and toxicity plays a central role in the pathophysiology of neuroinflammation. Magnetic resonance imaging (MRI) studies most consistently show reduced hippocampal volumes. Neural circuitry dysfunction such as hypoactivation between the ventral striatum and the ventromedial prefrontal cortex underlies the melancholic phenotype of depression. Chronic administration of monoamine-based antidepressants counters the inflammatory response, but with a delayed therapeutic onset. Therapeutics targeting cell mediated immunity, generalized and specific inflammatory signaling pathways, and nitro-oxidative stress have enormous potential to advance the treatment landscape. Future clinical trials will need to include immune system perturbations as biomarker outcome measures to facilitate novel antidepressant development. In this overview, we explore the inflammatory correlates of depression and elucidate pathomechanisms to facilitate the development of novel biomarkers and therapeutics.

Inflammation and the dimensions of depression: A review

The role of inflammation in core features of depression: Insights from paradigms using exogenously-induced inflammation

The fiery landscape of depression: A review of the inflammatory hypothesis.

The inflammatory underpinning of depression: An historical perspective

Neuroinflammation and depression: A review

Is Depression an Inflammatory Condition? A Review of Available Evidence.

Inflammatory biomarkers in depression: scoping review

Elevated Systemic Inflammation Is Associated with Reduced Corticolimbic White Matter Integrity in Depression

Recognizing depression as an inflammatory disease: the search for endotypes

The Interplay Between Stress, Inflammation, and Emotional Attention: Relevance for Depression

Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression

Inflammation and depression: a causal or coincidental link to the pathophysiology?

Brain-derived neurotrophic factor and inflammation in depression: Pathogenic partners in crime?

Inflammation and Immune Regulation as Potential Drug Targets in Antidepressant Treatment

The role of inflammation in depression: from evolutionary imperative to modern treatment target

Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories

Inflammation-Related Functional and Structural Dysconnectivity as a Pathway to Psychopathology

The Bidirectional Relationship of Depression and Inflammation: Double Trouble

Hierarchical Inflammatory Phenotypes of Depression: A Novel Approach Across Five Independent Samples and 27,730 Adults

Exploring the role of inflammation in major depressive disorder: beyond the monoamine hypothesis

Inflammatory Depression-Mechanisms and Non-Pharmacological Interventions